CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
68.43
-3.39 (-4.72%)
At close: Oct 16, 2025, 3:59 PM
67.67
-1.10%
After-hours: Oct 16, 2025, 07:59 PM EDT
-4.72% (1D)
| Bid | 68.04 |
| Market Cap | 6.22B |
| Revenue (ttm) | 37.36M |
| Net Income (ttm) | -467.8M |
| EPS (ttm) | -5.4 |
| PE Ratio (ttm) | -12.67 |
| Forward PE | -16.17 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 68.5 |
| Volume | 1,879,624 |
| Avg. Volume (20D) | 2,866,821 |
| Open | 69.95 |
| Previous Close | 71.82 |
| Day's Range | 67.87 - 71.52 |
| 52-Week Range | 30.04 - 78.48 |
| Beta | 1.83 |
| Ex-Dividend Date | n/a |
About CRSP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRSP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRSP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCRISPR Therapeutics AG is scheduled to release its earnings on
Nov 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-2.42%
Shares of precious metals stocks are trading lower...
Unlock content with
Pro Subscription
1 week ago
+8.72%
Shares of precious metals stocks are trading higher as gold and silver gain amid the US government shutdown, which could increase safe haven demand.
